5-fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer

Gastroenterology

Volumn 140, Issue 4, 2011, Pages 1174-1181

  Jover, Rodrigo ^a   Nguyen, Thuyphuong ^b   Prezcarbonell, Luca ^a   Zapater, Pedro ^a   Pay, Artemio ^a   Alenda, Cristina ^a   Rojas, Estefana ^a   Cubiella, Joaqun ^c   Balaguer, Francesc ^b,d   Morillas, Juan D ^e   Clofent, Juan ^f   Bujanda, Luis ^g   Re, Josep M ^h   Bessa, Xavier ⁱ   Xicola, Rosa M ^j   Nicolsprez, David ^k   Castells, Antoni ^d   Andreu, Montserrat ⁱ   Llor, Xavier ^j   Boland, C Richard ^b   Goel, Ajay ^b   more..

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c Departments of Pathology and Gastroenterology   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e Hospital de Madrid   (Spain)

^f HOSPITAL DO MEIXOEIRO   (Spain)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h HOSPITAL ARNAU DE VILANOVA   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^k HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

more..

Author keywords

5 FU Adjuvant Chemotherapy; Colon Cancer; DNA Methylation; Response to Cancer Therapy

Indexed keywords

FLUOROURACIL; NEUROGENIN 1; PROTEIN CACNAG1; PROTEIN MLH1; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

EID: 79953217628     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.12.035     Document Type: Article

References (34)

1. C.R. Boland, and A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 2010 2073 2087
2. J.M. Wheeler, W.F. Bodmer, and N.J. Mortensen DNA mismatch repair genes and colorectal cancer Gut 47 2000 148 153 (Pubitemid 30430425)
3. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2003 2042 2054 (Pubitemid 37448928)
4. N. Hawkins, M. Norrie, and K. Cheong CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability Gastroenterology 122 2002 1376 1387 (Pubitemid 34465180)
5. A. Goel, C.N. Arnold, and D. Niedzwiecki Characterization of sporadic colon cancer by patterns of genomic instability Cancer Res 63 2003 1608 1614 (Pubitemid 36373651)
6. T. Nagasaka, M. Koi, and M. Kloor Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer Gastroenterology 134 2008 1950 1960
7. A. Goel, T. Nagasaka, and C.N. Arnold The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer Gastroenterology 132 2007 127 138 (Pubitemid 46108731)
8. M.F. Kane, M. Loda, and G.M. Gaida Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines Cancer Res 57 1997 808 811 (Pubitemid 27097998)
9. D.J. Weisenberger, K.D. Siegmund, and M. Campan CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793 (Pubitemid 43980599)
10. J.R. Jass Classification of colorectal cancer based on correlation of clinical, morphological and molecular features Histopathology 50 2007 113 130 (Pubitemid 44953403)
11. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609 618 (Pubitemid 46224239)
12. J.M. Carethers, E.J. Smith, and C.A. Behling Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer Gastroenterology 126 2004 394 401 (Pubitemid 38182296)
13. C.M. Ribic, D.J. Sargent, and M.J. Moore Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257 (Pubitemid 36859476)
14. R. Jover, P. Zapater, and A. Castells Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer Gut 55 2006 848 855 (Pubitemid 43764557)
15. R. Jover, P. Zapater, and A. Castells The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status Eur J Cancer 45 2009 365 373
16. D.J. Sargent, S. Marsoni, and G. Monges Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 2010 3219 3226
17. A.M. Dahlin, R. Palmqvist, and M.L. Henriksson The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status Clin Cancer Res 16 2010 1845 1855
18. J.H. Kim, S.H. Shin, and H.J. Kwon Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers Virchows Arch 455 2009 485 494
19. S. Ogino, K. Nosho, and G.J. Kirkner CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 58 2009 90 96
20. S. Ogino, J.A. Meyerhardt, and T. Kawasaki CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma Virchows Arch 450 2007 529 537 (Pubitemid 46676250)
21. L. Shen, P.J. Catalano, and A.B. Benson III Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clin Cancer Res 13 2007 6093 6098 (Pubitemid 350075067)
22. R.M. Van, H. Elsaleh, and D. Joseph CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer Clin Cancer Res 9 2003 2898 2903 (Pubitemid 36993247)
23. G. Egger, G. Liang, and A. Aparicio Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463 (Pubitemid 38715140)
24. V. Pinol, M. Andreu, and A. Castells Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study Eur J Gastroenterol Hepatol 16 2004 39 45 (Pubitemid 39043701)
25. V. Pinol, A. Castells, and M. Andreu Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer JAMA 293 2005 1986 1994 (Pubitemid 40570892)
26. C.R. Boland, S.N. Thibodeau, and S.R. Hamilton A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257 (Pubitemid 28521189)
27. R.M. Xicola, X. Llor, and E. Pons Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors J Natl Cancer Inst 99 2007 244 252
28. A. Goel, T. Nagasaka, and R. Hamelin An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers PLoS One 5 2010 e9393
29. S. Benlloch, A. Paya, and C. Alenda Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology J Mol Diagn 8 2006 540 543 (Pubitemid 44774151)
30. A. Goel, R.M. Xicola, and T.P. Nguyen Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency Gastroenterology 138 2010 1854 1862
31. R.L. Ward, K. Cheong, and S.L. Ku Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability J Clin Oncol 21 2003 3729 3736 (Pubitemid 46606226)
32. L. Barault, C. Charon-Barra, and V. Jooste Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases Cancer Res 68 2008 8541 8546
33. L. Bujanda, C. Sarasqueta, and E. Hijona Colorectal cancer prognosis twenty years later World J Gastroenterol 16 2010 862 867
34. M. Ferracin, R. Gafa, and E. Miotto The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile J Pathol 214 2008 594 602 (Pubitemid 351482274)